Literature DB >> 24768957

Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the national surgical quality improvement program data.

Haider Mahdi1, Sarah Goodrich2, David Lockhart3, Robert DeBernardo2, Mehdi Moslemi-Kebria2.   

Abstract

STUDY
OBJECTIVE: To estimate the rate and predictors of surgical site infection (SSI) after hysterectomy performed for benign indications and to identify any association between SSI and other postoperative complications.
DESIGN: Retrospective cohort study (Canadian Task Force classification II-2).
SETTING: National Surgical Quality Improvement Program data. PATIENTS: Women who underwent abdominal or laparoscopic hysterectomy performed for benign indications from 2005 to 2011.
INTERVENTIONS: Univariable and multivariable logistic regression analyses were used to identify predictors of SSI and its association with other postoperative complications. Odds ratios were adjusted for patient demographic data, comorbidities, preoperative laboratory values, and operative factors.
MEASUREMENTS AND MAIN RESULTS: Of 28 366 patients, 758 (3%) were diagnosed with SSI. SSI occurred more often after abdominal than laparoscopic hysterectomy (4% vs 2%; p < .001). Among patients who underwent abdominal hysterectomy, predictors of SSI included diabetes, smoking, respiratory comorbidities, overweight or obesity, American Society of Anesthesiologists class ≥ 3, perioperative blood transfusion, and operative time >180 minutes. Among those who underwent laparoscopic hysterectomy, predictors of SSI included perioperative blood transfusion, operative time >180 minutes, serum creatinine concentration ≥ 2 mg/dL, and platelet count ≥ 350 000 cells/mL(3). For patients with deep or organ/space SSI, significant predictors included perioperative blood transfusion and American Society of Anesthesiologists class ≥ 3 for abdominal hysterectomy, and non-white race, renal comorbidities, preoperative or perioperative blood transfusion, and operative time >180 minutes for laparoscopic hysterectomy. SSI was associated with longer hospital stay and higher rates of repeat operation, sepsis, renal failure, and wound dehiscence. SSI was not associated with increased 30-day mortality.
CONCLUSIONS: SSI occurred more often after abdominal hysterectomy than laparoscopic hysterectomy performed to treat benign gynecologic disease. SSI was associated with increased postoperative complications but not mortality. Several risk factors for SSI after each abdominal and laparoscopic hysterectomy were identified in this study.
Copyright © 2014 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abdominal; Benign indications; Hysterectomy; Laparoscopic; Risk factors; Surgical site infection

Mesh:

Year:  2014        PMID: 24768957     DOI: 10.1016/j.jmig.2014.04.003

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  17 in total

1.  Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge: A Randomized Controlled Trial.

Authors:  Lisa Chao; Suketu Mansuria
Journal:  Obstet Gynecol       Date:  2019-05       Impact factor: 7.661

2.  Dual antibiotic prevention bundle is associated with decreased surgical site infections.

Authors:  Michelle Kuznicki; Adrianne Mallen; Emily Clair McClung; Sharon E Robertson; Sarah Todd; David Boulware; Stacy Martin; Rod Quilitz; Roberto J Vargas; Sachin M Apte
Journal:  Int J Gynecol Cancer       Date:  2020-07-29       Impact factor: 3.437

3.  Relationship between body mass index and operative time in women receiving immediate postpartum tubal ligation.

Authors:  Neha A Deshpande; Amanda Labora; Mary D Sammel; Courtney A Schreiber; Sarita Sonalkar
Journal:  Contraception       Date:  2019-05-10       Impact factor: 3.375

4.  A comparison of surgical outcomes among robotic cases performed with an employed surgical assist versus a second surgeon as the assist.

Authors:  Lindsey K Leggett; Olga Muldoon; David L Howard; Lynn D Kowalski
Journal:  J Robot Surg       Date:  2021-03-26

5.  Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database.

Authors:  Michael D Toboni; Haller J Smith; Sejong Bae; J Michael Straughn; Charles A Leath
Journal:  Int J Gynecol Cancer       Date:  2018-09       Impact factor: 3.437

6.  Early catheter removal after pelvic floor reconstructive surgery: a randomized trial.

Authors:  Charelle M Carter-Brooks; Halina M Zyczynski; Pamela A Moalli; Peter G Brodeur; Jonathan P Shepherd
Journal:  Int Urogynecol J       Date:  2018-03-29       Impact factor: 2.894

7.  A Novel Nomogram for Predicting Postsurgical Intra-abdominal Infection in Gastric Cancer Patients: a Prospective Study.

Authors:  Chen-Chen Mao; Xiao-Dong Chen; Ji Lin; Wei-Shan Zhu-Ge; Zhong-Dong Xie; Xi-Yi Chen; Feng-Min Zhang; Rui-Sen Wu; Wei-Teng Zhang; Neng Lou; Li Shi; Guan-Bao Zhu; Xian Shen
Journal:  J Gastrointest Surg       Date:  2018-01-12       Impact factor: 3.452

8.  Racial/Ethnic Differences in the Risk of Surgical Complications and Posthysterectomy Hospitalization among Women Undergoing Hysterectomy for Benign Conditions.

Authors:  Lisa M Pollack; Jerry L Lowder; Matt Keller; Su-Hsin Chang; Sarah J Gehlert; Margaret A Olsen
Journal:  J Minim Invasive Gynecol       Date:  2021-01-01       Impact factor: 4.137

9.  Pancreatoduodenectomy within 2 weeks after endoscopic retrograde cholangio-pancreatography increases the risk of organ/space surgical site infections: a 5-year retrospective cohort study in a high-volume centre.

Authors:  Wensen Chen; Kai Zhang; Zhongheng Zhang; Zipeng Lu; Daoquan Zhang; Juan Liu; Yue Yang; Yinzhi Leng; Yongxiang Zhang; Weihong Zhang; Kuirong Jiang; Guihua Zhuang; Yi Miao; Yun Liu
Journal:  Gland Surg       Date:  2021-06

10.  Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Rosalie J Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.